Related Experiment Videos

Inflammatory and immunological parameters in children with haemolytic uremic syndrome (HUS) and

S Westerholt1, T Hartung, M Tollens

  • 1Children's Hospital of the Technical University of Munich, Munich, Germany. Soeren.Westerholt@lrz.tum.de

Cytokine
|June 14, 2000
PubMed

Insights

Identifying early risk factors for hemolytic uremic syndrome (HUS) in children with EHEC diarrhea is crucial. Low neopterin and IL-10, along with high IL-8, indicate a significant risk for developing D+HUS.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Immunology

Background:

  • Enterohaemorrhagic Escherichia coli (EHEC) infections can lead to diarrhea and hemolytic uremic syndrome (HUS).
  • Early identification of children at risk for developing D+HUS is critical for timely intervention.
  • Understanding the prodromal phase immune response may reveal predictive biomarkers.

Purpose of the Study:

  • To identify serum inflammatory markers that predict the risk of developing typical diarrhea-associated hemolytic uremic syndrome (D+HUS) in children with EHEC infection.
  • To differentiate these markers from those observed in other forms of bacterial and viral gastroenteritis.

Main Methods:

  • Prospective study of 48 children admitted to the hospital with diarrhea.
  • Analysis of serum inflammatory factors including Interleukin-8 (IL-8), Neopterin, and Interleukin-10 (IL-10) on admission.
  • Comparison of marker levels between children who developed D+HUS and those with viral or other bacterial gastroenteritis.

Main Results:

  • Mean IL-8 levels tended to be higher in the D+HUS group compared to gastroenteritis groups.
  • Neopterin and IL-10 levels were significantly decreased in children who developed D+HUS compared to both gastroenteritis groups.
  • Low IL-10 levels suggest immune response dysregulation, as IL-10 normally downregulates inflammation.

Conclusions:

  • Low serum neopterin, high IL-8, and particularly low IL-10 levels are significant indicators of a high risk for developing D+HUS in children with EHEC-induced diarrhea.
  • These findings highlight the potential of specific inflammatory markers for early risk stratification in pediatric EHEC infections.

Related Concept Videos

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...